Denys-Drash Syndrome

Oncology·MeSH: Denys-Drash Syndrome

Prevalence

0.1 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Denys-Drash Syndrome?

There are 1 clinical trial targeting Denys-Drash Syndrome tracked by BioSniper.

What is the prevalence of Denys-Drash Syndrome?

The estimated prevalence of Denys-Drash Syndrome is approximately 0.1 per 100,000 population.

Deep-dive into Denys-Drash Syndrome

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Denys-Drash Syndrome — Drugs in Development & Clinical Trials | BioSniper